高CEBPB的休眠瘤细胞通过S100A8编排的瘤相关巨细胞重编程驱动免疫逃避
Jin Bai1,2, Huilan Su3, Shunxi Wang4,5
1Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, 150 Jimo Road, Pudong District, Shanghai, 200120, China.
Theranostics
|March 9, 2026
概括
三阴性乳腺癌 (TNBC) 细胞通过保持休眠状态来逃避免疫治疗. 向CEPB-S100A8通路可以克服这种抵抗,并提高免疫检查点阻塞 (ICB) 治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 对免疫检查点阻塞 (ICB) 的反应不佳.
- 休眠瘤细胞是免疫疗法耐药性和潜在瘤复发的重要储备.
- 在TNBC中瘤休眠和免疫逃避背后的机制需要进一步阐明.
研究的目的:
- 确定在接受ICB治疗的TNBC患者中维持瘤休眠的关键因素.
- 调查已识别的因素在免疫逃避中的作用及其作为治疗点的潜力.
- 阐明TNBC中瘤休眠,免疫抑制和ICB抵抗之间的分子机制.
主要方法:
- 利用公开的scRNA-seq数据来识别休眠的TNBC细胞.
- 采用了TetOn-H2BeGFP系统,用于体内和体外追踪休眠细胞.
- 执行CCK-8,殖民地形成,PI染色,流细胞计,IHC,多重免疫光学,RNA-seq和ChIP-seq以识别和验证CEPB的作用和下游目标.
主要成果:
- 休眠的TNBC细胞在免疫抑制利基 (M2巨细胞,低CD8+T细胞) 中被发现具有ICB耐药性.
- 鉴定出CEPBPB在休眠细胞中表达高,通过激活细胞循环抑制剂 (如CCNG2) 维持休眠状态.
- 通过巨细胞的招募和极化,CEPBPB促进了免疫抑制的微环境,S100A8被确定为M2极化的关键目标.
结论:
- 在TNBC中建立了瘤休眠和免疫逃避之间的机械联系.
- 突出了CEPB-S100A8轴作为免疫抑制和ICB抵抗的关键调解器.
- 证明向CEPB或S100A8可以克服ICB抵抗,并重塑瘤微环境以提高治疗效果.
相关概念视频
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K


